415 related articles for article (PubMed ID: 21364523)
1. The biological and therapeutic relevance of mRNA translation in cancer.
Blagden SP; Willis AE
Nat Rev Clin Oncol; 2011 May; 8(5):280-91. PubMed ID: 21364523
[TBL] [Abstract][Full Text] [Related]
2. Targeting the translation machinery in cancer.
Bhat M; Robichaud N; Hulea L; Sonenberg N; Pelletier J; Topisirovic I
Nat Rev Drug Discov; 2015 Apr; 14(4):261-78. PubMed ID: 25743081
[TBL] [Abstract][Full Text] [Related]
3. Targeting Translation of mRNA as a Therapeutic Strategy in Cancer.
Pal I; Safari M; Jovanovic M; Bates SE; Deng C
Curr Hematol Malig Rep; 2019 Aug; 14(4):219-227. PubMed ID: 31231778
[TBL] [Abstract][Full Text] [Related]
4. The plasticity of mRNA translation during cancer progression and therapy resistance.
Fabbri L; Chakraborty A; Robert C; Vagner S
Nat Rev Cancer; 2021 Sep; 21(9):558-577. PubMed ID: 34341537
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
6. Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target.
Jia Y; Polunovsky V; Bitterman PB; Wagner CR
Med Res Rev; 2012 Jul; 32(4):786-814. PubMed ID: 22495651
[TBL] [Abstract][Full Text] [Related]
7. Targeting translation regulators improves cancer therapy.
Jiang SL; Mo JL; Peng J; Lei L; Yin JY; Zhou HH; Liu ZQ; Hong WX
Genomics; 2021 Jan; 113(1 Pt 2):1247-1256. PubMed ID: 33189778
[TBL] [Abstract][Full Text] [Related]
8. Translating Hedgehog in Cancer: Controlling Protein Synthesis.
D'Amico D; Canettieri G
Trends Mol Med; 2016 Oct; 22(10):851-862. PubMed ID: 27591077
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted control of mRNA translation machinery in cancer.
Alboushi L; Hackett AP; Naeli P; Bakhti M; Jafarnejad SM
Cell Signal; 2021 Aug; 84():110037. PubMed ID: 33975011
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic translation initiation factors as promising targets in cancer therapy.
Hao P; Yu J; Ward R; Liu Y; Hao Q; An S; Xu T
Cell Commun Signal; 2020 Nov; 18(1):175. PubMed ID: 33148274
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of mRNA translation and energy metabolism in cancer.
Leibovitch M; Topisirovic I
Adv Biol Regul; 2018 Jan; 67():30-39. PubMed ID: 29150352
[TBL] [Abstract][Full Text] [Related]
12. Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control.
Kim HJ
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31671902
[TBL] [Abstract][Full Text] [Related]
13. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies.
Hagner PR; Schneider A; Gartenhaus RB
Blood; 2010 Mar; 115(11):2127-35. PubMed ID: 20075156
[TBL] [Abstract][Full Text] [Related]
14. Repression of human thymidylate synthase mRNA translation by antisense 2'-O-methyl oligoribonucleotides.
Schmitz JC; Agrawal S; Chu E
Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):371-8. PubMed ID: 9826264
[TBL] [Abstract][Full Text] [Related]
15. Translational control of aberrant stress responses as a hallmark of cancer.
El-Naggar AM; Sorensen PH
J Pathol; 2018 Apr; 244(5):650-666. PubMed ID: 29293271
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
[TBL] [Abstract][Full Text] [Related]
17. Translation regulation as a therapeutic target in cancer.
Grzmil M; Hemmings BA
Cancer Res; 2012 Aug; 72(16):3891-900. PubMed ID: 22850420
[TBL] [Abstract][Full Text] [Related]
18. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment.
Piserà A; Campo A; Campo S
J Genet Genomics; 2018 Jan; 45(1):13-24. PubMed ID: 29396141
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms governing the control of mRNA translation.
Livingstone M; Atas E; Meller A; Sonenberg N
Phys Biol; 2010 May; 7(2):021001. PubMed ID: 20463379
[TBL] [Abstract][Full Text] [Related]
20. RNA-modifying proteins as anticancer drug targets.
Boriack-Sjodin PA; Ribich S; Copeland RA
Nat Rev Drug Discov; 2018 Jun; 17(6):435-453. PubMed ID: 29773918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
